DJIA 15,925.45 -101.60 -0.63%
NASDAQ 4,269.11 -14.65 -0.34%
S&P 500 1,846.31 -7.13 -0.38%
market minute promo

Johnson & Johnson (NYSE: JNJ)

101.34 -0.66 (-0.65%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

JNJ $101.32 -0.67%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $101.31
Previous Close $102.00
Daily Range $100.97 - $102.09
52-Week Range $81.79 - $105.49
Market Cap $280.4B
P/E Ratio 15.09
Dividend (Yield) $3.00 (2.9%)
Ex-Dividend Date
Dividend Pay Date
Volume 1,915,991
Average Daily Volume 10,046,044
Current FY EPS $6.18




Drug Makers

Johnson & Johnson (JNJ) Description

A vast and diverse health care giant, Johnson & Johnson strives to help people get well through its consumer products, pharmaceuticals, and medical devices. Website:

News & Commentary

1 Chart That's Bringing Big Smiles to America's Largest Companies

You might be witnessing a sea of red, but the recent retracement in this index could be a very good thing for America's largest companies.

2016 Bear Market Survival Guide For Dividend Investors

3 Health Care Stocks On The Rise

How To Invest In An Aging World With The 'Live Long & Prosper' ETF

S&P 500 Index Futures Sharply Lower

Dow Movers: GS, JNJ

Which Of The Latest 13F Filers Holds Johnson & Johnson

Protection For A Correction: A Hedging Strategy For Long-Term Dividend Investors

3 Potential Blockbusters Moving the Needle for Big Pharma in 2016

These pharmas have some recently approved drugs that could singlehandedly boost total sales this year.

Biogen Inc. Takes Aim at Johnson & Johnson

Biogen's Samsung Bioepis has Remicade in its crosshairs.

See More JNJ News...

JNJ's Top Competitors

JNJ $101.34 (-0.65%)
Current stock: JNJ
PFE $28.47 (-0.33%)
Current stock: PFE
MRK $48.69 (-0.29%)
Current stock: MRK
BSX $16.66 (3.67%)
Current stock: BSX